These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9188608)

  • 1. High level of transgene expression in cell cultures and in the mouse by replication-incompetent adenoviruses harboring modified VAI genes.
    Eloit M; Adam M; Gallais I; Fournier A
    J Virol; 1997 Jul; 71(7):5375-81. PubMed ID: 9188608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo.
    Schowalter DB; Tubb JC; Liu M; Wilson CB; Kay MA
    Gene Ther; 1997 Apr; 4(4):351-60. PubMed ID: 9176522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.
    Carette JE; Graat HC; Schagen FH; Abou El Hassan MA; Gerritsen WR; van Beusechem VW
    J Gene Med; 2005 Aug; 7(8):1053-62. PubMed ID: 15756711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart muscle-specific gene expression using replication defective recombinant adenovirus.
    Rothmann T; Katus HA; Hartong R; Perricaudet M; Franz WM
    Gene Ther; 1996 Oct; 3(10):919-26. PubMed ID: 8908506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
    Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
    J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
    Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
    J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
    Amalfitano A; Begy CR; Chamberlain JS
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo.
    Levrero M; Barban V; Manteca S; Ballay A; Balsamo C; Avantaggiati ML; Natoli G; Skellekens H; Tiollais P; Perricaudet M
    Gene; 1991 May; 101(2):195-202. PubMed ID: 1829048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus.
    Gao GP; Engdahl RK; Wilson JM
    Hum Gene Ther; 2000 Jan; 11(1):213-9. PubMed ID: 10646652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
    Song W; Kong HL; Traktman P; Crystal RG
    Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-interferon activity of adenovirus-2-encoded VAI and VAII RNAs in translation in cultured human cells.
    Mori K; Jüttermann R; Wienhues U; Kobayashi K; Yagi M; Sugimoto T; Tjia ST; Doerfler W; Hosokawa K
    Virus Res; 1996 Jun; 42(1-2):53-63. PubMed ID: 8806174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
    Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
    Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
    Lieber A; He CY; Kirillova I; Kay MA
    J Virol; 1996 Dec; 70(12):8944-60. PubMed ID: 8971024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
    Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
    Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
    Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
    Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.